(RTTNews) - Eli Lilly and Company (LLY) Tuesday said it has released 2.5 mg and 5 ... and GLP-1 (glucagon-like peptide-1) to reduce appetite and food intake. "These new vials not only help us ...

and a similar supply of the 5 mg vials at $529 -- about half what a month's supply of other GLP-1 obesity meds cost. There's ...

Eli Lilly, maker of one of the blockbuster GLP-1 weight-loss drug Zepbound, says it will now offer the medication in single-dose vials at half the price.

The drug company said the vials are available through its LillyDirect self-pay channel with a four-week supply of the 2.5 mg vial to be priced at $399 and a four-week supply of the 5 mg vial to be ...

and a similar supply of the 5 mg vials at $529 -- about half what a month's supply of other GLP-1 obesity meds cost. Related Study shows shift in GLP-1 drug use for obesity, not diabetes Weight ...

The single-dose vials are ... tirzepatide 5 mg, along with a reduced calorie diet and increased physical activity, achieved an average of 15% weight loss over 72 weeks compared to 3.1% for placebo.

INDIANAPOLIS — Eli Lilly is releasing single-dose vials ... mg, the highest dose, participants taking Zepbound lost 48 pounds on average, while people lost an average of 34 pounds on the lowest 5 mg ...

Under the new offering, which is meant for patients paying on their own without insurance, 2.5-mg vials will cost $399 for one month’s supply, and 5-mg vials will cost $549. Lilly says the price ...

This form of Zepbound is sold as a vial that needs to be given by a syringe, although patients can still do it themselves. Zepbound and Mounjaro are both brand names for tirzepatide. However ...

The drug company said the vials are available through its LillyDirect self-pay channel with a four-week supply of the 2.5 mg vial to be priced ... gut hormones, GLP-1 and GIP by reducing appetite.